These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 9586335)

  • 41. Concurrent administration of rhesus rotavirus tetravalent (RRV-TV) vaccine with pentavalent diphtheria-pertussis-tetanus-Haemophilus influenzae beta-inactivated polio and hepatitis B vaccines.
    Vesikari T; Joensuu J; Baer M; Käyhty H; Olander RM; Sormunen H; Miettinen A; Ward RL; Guillot T
    Acta Paediatr; 1999 May; 88(5):513-20. PubMed ID: 10426173
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Need for polio boosters after age two years.
    Rennels MB
    Vaccine; 2009 Jan; 27(2):179-80. PubMed ID: 19007837
    [No Abstract]   [Full Text] [Related]  

  • 43. Polio eradication: the endgame.
    Nat Med; 2001 Feb; 7(2):131. PubMed ID: 11175817
    [No Abstract]   [Full Text] [Related]  

  • 44. Polio eradication in India: how far are we from reaching the goal?
    Banerjee K; Sahu S; Bandyopadhyay S
    Indian J Pediatr; 2001 Mar; 68 Suppl 1():S6-14. PubMed ID: 11411387
    [No Abstract]   [Full Text] [Related]  

  • 45. An explosive outbreak of poliomyelitis in an orphanage in Delhi: risk factors for the unusually high attack rates.
    Singh J; Khare S; Sharma RS; Verghese T
    Indian Pediatr; 1997 Feb; 34(2):135-9. PubMed ID: 9255009
    [No Abstract]   [Full Text] [Related]  

  • 46. [An analysis of the medical contraindications for poliomyelitis vaccination in a district of the city of Bucharest].
    Ion-Nedelcu N; Mihăileanu C; Dobrescu A
    Bacteriol Virusol Parazitol Epidemiol; 1991; 36(1):18-22. PubMed ID: 1802288
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Changing poliovirus vaccine policy can be controversial at best.
    Faden H
    Adv Pediatr Infect Dis; 1997; 13():305-32. PubMed ID: 9544317
    [No Abstract]   [Full Text] [Related]  

  • 48. [Results of polio vaccinations with the Salk vaccine in North-Rhine-Westphalia during 1957-1961].
    Trüb CL; Posch J
    Zentralbl Bakteriol Orig; 1965 Feb; 195(3):295-320. PubMed ID: 4285366
    [No Abstract]   [Full Text] [Related]  

  • 49. [The perspective of global eradication of poliomyelitis].
    Knolle H; Egli A; Candrian U
    Gesundheitswesen; 2004 Jan; 66(1):1-6. PubMed ID: 14767784
    [TBL] [Abstract][Full Text] [Related]  

  • 50. When can we stop using oral poliovirus vaccine?
    Hull HF; Minor PD
    J Infect Dis; 2005 Dec; 192(12):2033-5. PubMed ID: 16288363
    [No Abstract]   [Full Text] [Related]  

  • 51. [Evaluation of the response to vaccination against poliomyelitis and measles in malnourished children in Morocco].
    Caidi H; Bennis IF; Mouan N; El Aouad R
    East Mediterr Health J; 2004; 10(4-5):474-81. PubMed ID: 16335637
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Seroprevalence of poliovirus antibodies among children in a Dominican community--Puerto Rico, 2002.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2005 Jun; 54(23):580-1. PubMed ID: 15959453
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Study on factors affecting vaccination effect of poliomyelitis vaccine].
    Chai F; Zhang R
    Zhonghua Liu Xing Bing Xue Za Zhi; 1994 Oct; 15(5):267-70. PubMed ID: 7859258
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An adolescent-adult formulation tetanus and diptheria toxoids adsorbed combined with acellular pertussis vaccine has comparable immunogenicity but less reactogenicity in children 4-6 years of age than a pediatric formulation acellular pertussis vaccine and diphtheria and tetanus toxoids adsorbed combined with inactivated poliomyelitis vaccine.
    Langley JM; Predy G; Guasparini R; Law B; Diaz-Mitoma F; Whitstitt P; Tapiero B; Dionne M; Tomovici A; Mills E; Halperin SA
    Vaccine; 2007 Jan; 25(6):1121-5. PubMed ID: 17045366
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Poliomyelitis: state of the art].
    Patti AM
    Ann Ig; 2002; 14(4 Suppl 4):1-16. PubMed ID: 12389420
    [No Abstract]   [Full Text] [Related]  

  • 56. OPV cannot eradicate polio from India: do we need any further evidence?
    Paul Y
    Vaccine; 2008 Apr; 26(17):2058-61. PubMed ID: 18378367
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Circulation of the poliovirus in endemic zones with children vaccinated by the oral polio vaccine].
    Gouandjika I; Rakoto Andrianarivelo M; Akoua-Koffi C; Zeller H; Ehouman A; Morvan JM
    Bull Soc Pathol Exot; 2000 Jul; 93(3):198-201. PubMed ID: 11030057
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Progress toward global poliomyelitis eradication, 1999.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2000 Apr; 49(16):349-54. PubMed ID: 10817482
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inactivated poliovirus vaccine in Finland.
    Oker-Blom N; Penttinen K; Weckström P
    Rev Infect Dis; 1984; 6 Suppl 2():S461-2. PubMed ID: 6330842
    [No Abstract]   [Full Text] [Related]  

  • 60. [Type I poliovirus isolated in 4 migrant children with paralysis].
    Ruffault A; Hegaret A; Fauconnier B
    Nouv Presse Med; 1978 Jun; 7(24):2174-5. PubMed ID: 210443
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.